Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer.
Phase of Trial: Phase III
Latest Information Update: 09 Dec 2017
At a glance
- Drugs Goserelin (Primary) ; Cyclophosphamide
- Indications Primary ovarian insufficiency
- Focus Therapeutic Use
- Acronyms POEMS
- 31 Aug 2018 Biomarkers information updated
- 09 Dec 2017 Results of final analysis of the study (five-year follow up) , presented at the 40th Annual San Antonio Breast Cancer Symposium.
- 28 Oct 2016 Status changed from active, no longer recruiting to completed.